FLT4 and cancer: VEGFR3 is highly expressed in lymphatic endothelial cells during development, but becomes downregulated in the adult, being maintained at low levels unless induced by pathological situations such as cancer (Petrova et al, 2008; Martinez‐Corral et al, 2012).